BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Konstantinos Tziomalos, Vasilios G. Athyros, Paschalis Paschos, Asterios Karagiannis. Nonalcoholic fatty liver disease and statinsMetabolism 2015; 64(10): 1215 doi: 10.1016/j.metabol.2015.07.003
2
Timothy M.E. Davis, Kirsten E. Peters, S. A. Paul Chubb, Leon A. Adams, Gary P. Jeffrey, Wendy A. Davis. Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes StudyJournal of Clinical Medicine 2020; 9(11): 3409 doi: 10.3390/jcm9113409
3
Stephen A. Harrison, Mark M. Pence, Amy N. Stratton, Dawn M. Torres. Zakim and Boyer's Hepatology2018; : 406 doi: 10.1016/B978-0-323-37591-7.00027-6
4
Hua Cao, Zhi-Xiang Chen, Kai Wang, Meng-Meng Ning, Qing-An Zou, Ying Feng, Yang-Liang Ye, Ying Leng, Jian-Hua Shen. Intestinally-targeted TGR5 agonists equipped with quaternary ammonium have an improved hypoglycemic effect and reduced gallbladder filling effectScientific Reports 2016; 6(1) doi: 10.1038/srep28676
5
Steven C. Lin, Brandon Ang, Carolyn Hernandez, Ricki Bettencourt, Rashmi Jain, Joanie Salotti, Lisa Richards, Yuko Kono, Archana Bhatt, Hamed Aryafar, Grace Y. Lin, Mark A. Valasek, Claude B. Sirlin, Sharon Brouha, Rohit Loomba. Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trialTherapeutic Advances in Gastroenterology 2016; 9(2): 152 doi: 10.1177/1756283X15621232
6
Niki Katsiki, Dimitri P. Mikhailidis, Christos S. Mantzoros. Non-alcoholic fatty liver disease and dyslipidemia: An updateMetabolism 2016; 65(8): 1109 doi: 10.1016/j.metabol.2016.05.003
7
Carla Sá, Ana Rita Oliveira, Cátia Machado, Marisa Azevedo, Cristina Pereira-Wilson. Effects on Liver Lipid Metabolism of the Naturally Occurring Dietary Flavone Luteolin-7-glucosideEvidence-Based Complementary and Alternative Medicine 2015; 2015: 1 doi: 10.1155/2015/647832
8
Aybike Birerdinc, Zobair Younossi. Can NASH lipidome provide insight into the pathogenesis of obesity-related non-alcoholic fatty liver disease?Journal of Hepatology 2015; 62(4): 761 doi: 10.1016/j.jhep.2015.01.005
9
Graciela Arguello, Elisa Balboa, Marco Arrese, Silvana Zanlungo. Recent insights on the role of cholesterol in non-alcoholic fatty liver diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015; 1852(9): 1765 doi: 10.1016/j.bbadis.2015.05.015